Fatal dysrhythmia following potassium replacement for hypokalemic periodic paralysis.
We present a case of fatal rebound hyperkalemia in a patient with thyrotoxic periodic paralysis (TPP) treated with potassium supplementation. Although TPP is a rare hyperthyroidism-related endocrine disorder seen predominantly in men of Asian origin, the diagnosis should be considered in patients of non-Asian origins presenting with hypokalemia, muscle weakness or acute paralysis. The condition may present as a life threatening emergency and unfamiliarity with the disease could result in a fatal outcome. Immediate therapy with potassium chloride supplementation may foster a rapid recovery of muscle strength and prevent cardiac arrhythmias secondary to hypokalemia, but with a risk of rebound hyperkalemia.
Ahmed
Imdad
I
University of Minnesota Medical School, Minneapolis MN.
Chilimuri
Sridhar S
SS
Arch Intern Med. 1989 Nov;149(11):2597-600
2818118
South Med J. 1996 Jul;89(7):735-7
8685766
Ann Neurol. 1982 Jun;11(6):547-52
6287910
Ann Emerg Med. 1994 Oct;24(4):736-40
8092604
Arch Intern Med. 1981 Jan;141(1):49-53
7447584
Emerg Med J. 2003 Sep;20(5):E7
12954712
Medicine (Baltimore). 1992 May;71(3):109-20
1635436
J Emerg Med. 2000 Feb;18(2):199-202
10699522
Arch Intern Med. 1999 Mar 22;159(6):601-6
10090117
Am J Kidney Dis. 2001 Mar;37(3):620-3
11228188
Emerg Med J. 2002 Jan;19(1):78-9
11777887
Am J Cardiol. 2003 Mar 15;91(6):775-7
12633825
J Clin Endocrinol Metab. 2006 Jul;91(7):2490-5
16608889
Mayo Clin Proc. 2005 Jan;80(1):99-105
15667036
Medicine (Baltimore). 1981 Sep;60(5):339-54
6268928
Am J Emerg Med. 2004 Nov;22(7):544-7
15666258